blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP1225168

EP1225168 - Prostaglandin-F-2 alpha derivative for the treatment of glaucoma or ocular hypertension [Right-click to bookmark this link]
Former [2002/30]Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
[2013/21]
StatusPatent maintained as amended
Status updated on  19.12.2014
Database last updated on 23.11.2024
Most recent event   Tooltip03.11.2015Change - lapse in a contracting state
Updated state(s): ES		published on 02.12.2015  [2015/49]
Applicant(s)For all designated states
Pfizer Health AB
112 87 Stockholm / SE
[2004/31]
Former [2002/30]For all designated states
Pharmacia AB
112 87 Stockholm / SE
Inventor(s)01 / Stjernschantz, Johan W.
Villavägen 1B
752 38 Uppsala / SE
02 / Resul, Bahram
Vitkalsgatan 112
754 49 Uppsala / SE
 [2002/30]
Representative(s)Pfizer
European Patent Department
23-25 avenue du Docteur Lannelongue
75668 Paris Cedex 14 / FR
[2012/32]
Former [2011/52]Ruddock, Keith Stephen, et al
Pfizer Limited
European Patent Department
Ramsgate Road
Sandwich, Kent CT13 9NJ / GB
Former [2008/35]Kingsbury, Oliver William, et al
Pfizer Limited European Patent Department Ramsgate Road Sandwich
Kent CT13 9NJ / GB
Former [2002/30]HOFFMANN - EITLE
Patent- und Rechtsanwälte Arabellastrasse 4
81925 München / DE
Application number, filing date02009255.706.09.1989
[2002/30]
Priority number, dateSE1988000311006.09.1988         Original published format: SE 8803110
SE1988000385528.10.1988         Original published format: SE 8803855
[2002/30]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP1225168
Date:24.07.2002
Language:EN
[2002/30]
Type: A3 Search report 
No.:EP1225168
Date:26.03.2003
[2003/13]
Type: B1 Patent specification 
No.:EP1225168
Date:14.01.2009
Language:EN
[2009/03]
Type: B2 New European patent specification 
No.:EP1225168
Date:21.01.2015
Language:EN
[2015/04]
Type: B8 Corrected title page of specification 
No.:EP1225168
Date:18.03.2015
[2015/12]
Search report(s)(Supplementary) European search report - dispatched on:EP11.02.2003
ClassificationIPC:A61K31/5575, A61P27/06, A61P27/02
[2013/21]
CPC:
C07C405/00 (EP,US); A61K31/557 (EP,US); A61K31/5575 (EP,US);
A61K31/5578 (EP,US); A61P27/00 (EP); A61P27/02 (EP);
A61P27/06 (EP); A61P9/02 (EP) (-)
Former IPC [2003/13]C07C405/00, A61K31/557, A61P27/02
Former IPC [2002/30]C07C405/00, // A61K31/557
Designated contracting statesAT,   BE,   CH,   DE,   ES,   FR,   GB,   GR,   IT,   LI,   LU,   NL,   SE [2002/30]
TitleGerman:Prostaglandin-F-2-alpha Derivat zur Behandlung von Glaukom und Augenhochdruck[2013/21]
English:Prostaglandin-F-2 alpha derivative for the treatment of glaucoma or ocular hypertension[2013/21]
French:Dérivé de prostaglandine-F-2-alpha pour le traitement du glaucome et de l'hypertension oculaire[2013/21]
Former [2002/30]Prostaglandin-Derivate zur Behandlung von Glaukom und ocularer Hypertension
Former [2002/30]Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension
Former [2002/30]Dérivés de prostaglandines pour le traitement du glaucome et de l'hypertension oculaire
Examination procedure26.04.2002Examination requested  [2002/30]
26.03.2008Despatch of a communication from the examining division (Time limit: M04)
17.07.2008Reply to a communication from the examining division
12.08.2008Observations by third parties
17.11.2008Communication of intention to grant the patent
02.12.2008Fee for grant paid
02.12.2008Fee for publishing/printing paid
Public notification(s)Interlocutory decision in opposition proceedings (Art. 101(3)(a) and 106(2) EPC), EPO Forms 2327, 2916 and annexes of 06.12.2013
ALAPIS S.A.
Aftokratoros Nikolaou Str. 1
17671 Athens / GR
[2014/20]
Parent application(s)   TooltipEP89850294.3  / EP0364417
EP93109514.5  / EP0569046
Opposition(s)Opponent(s)01  11.07.2009  21.06.2012  WITHDRAWN
Breath Limited
100 Paynesfield Road Tatsfield
Westerham TN16 2BQ / GB
Opponent's representative
Schlich, George William, et al, et al
Schlich
9 St. Catherine's Road
Littlehampton, West Sussex BN17 5HS / GB
 02  31.07.2009  10.08.2009  ADMISSIBLE
Lareq Pharma SL
Calle Caléndula 93 Edificio G, Miniparc III, Urbanizaciõn El Soto
Alcobendas Madrid / ES
Opponent's representative
Nohlen, Martin, et al, et al
Uexküll & Stolberg Partnerschaft von
Patent- und Rechtsanwälten mbB
Beselerstrasse 4
22607 Hamburg / DE
 03  17.08.2009  16.09.2009  WITHDRAWN
Generics (UK) Limited Mylan Italy, Mylan S.p.A Mylan Spain, Mylan Pharmaceuticals, S.L.
Albany Gate, Darkes Lane Via Vittor Pisani 20 C/Plom 2-4, 5a planta
Potter Bar EN6 1AG, 20124 Milano, 08038 Barcelona / GB
Opponent's representative
Elend, Almut Susanne, et al, et al
Venner Shipley LLP
406 Science Park
Milton Road
Cambridge CB4 0WW / GB
 04  12.10.2009  08.05.2012  WITHDRAWN
Ratiopharm GmbH
Graf-Arco-Strasse 3
89079 Ulm / DE
Opponent's representative
Breuer, Markus, et al, et al
Henkel, Breuer & Partner
Patentanwälte
Erika-Mann-Straße 23
80636 München / DE
 05  13.10.2009  02.11.2009  ADMISSIBLE
ALAPIS S.A.
Aftokratoros Nikolaou Str. 1
17671 Athens / GR
 [N/P]
Former [2014/02]
Opponent(s)01  11.07.2009  21.06.2012  WITHDRAWN
Breath Limited
100 Paynesfield Road Tatsfield
Westerham TN16 2BQ / GB
Opponent's representative
Schlich, George, et al, et al
Schlich LLP
9 St Catherine's Road
Littlehampton
West Sussex BN17 5HS / GB
 02  31.07.2009  10.08.2009  ADMISSIBLE
Lareq Pharma SL
Calle Caléndula 93 Edificio G, Miniparc III, Urbanizaciõn El Soto
Alcobendas Madrid / ES
Opponent's representative
Nohlen, Martin, et al, et al
Uexküll & Stolberg Patentanwälte Beselerstrasse 4
22607 Hamburg / DE
 03  17.08.2009  16.09.2009  WITHDRAWN
Generics (UK) Limited Mylan Italy, Mylan S.p.A Mylan Spain, Mylan Pharmaceuticals, S.L.
Albany Gate, Darkes Lane Via Vittor Pisani 20 C/Plom 2-4, 5a planta
Potter Bar EN6 1AG, 20124 Milano, 08038 Barcelona / GB
Opponent's representative
Elend, Almut Susanne, et al, et al
Venner Shipley LLP
Byron House
Cambridge Business Park
Cowley Road
Cambridge, Cambridgeshire CB4 0WZ / GB
 04  12.10.2009  08.05.2012  WITHDRAWN
Ratiopharm GmbH
Graf-Arco-Strasse 3
89079 Ulm / DE
Opponent's representative
Breuer, Markus, et al, et al
Henkel, Breuer & Partner
Patentanwälte
Erika-Mann-Straße 23
80636 München / DE
 05  13.10.2009  02.11.2009  ADMISSIBLE
ALAPIS S.A.
Aftokratoros Nikolaou Str. 1
17671 Athens / GR
Former [2013/18]
Opponent(s)01  11.07.2009  21.06.2012  WITHDRAWN
Breath Limited
100 Paynesfield Road Tatsfield
Westerham TN16 2BQ / GB
Opponent's representative
Schlich, George William, et al, et al
Schlich LLP
9 St Catherine's Road
Littlehampton
West Sussex BN17 5HS / GB
 02  31.07.2009  10.08.2009  ADMISSIBLE
Lareq Pharma SL
Calle Caléndula 93 Edificio G, Miniparc III, Urbanizaciõn El Soto
Alcobendas Madrid / ES
Opponent's representative
Nohlen, Martin, et al, et al
Uexküll & Stolberg Patentanwälte Beselerstrasse 4
22607 Hamburg / DE
 03  17.08.2009  16.09.2009  WITHDRAWN
Generics (UK) Limited Mylan Italy, Mylan S.p.A Mylan Spain, Mylan Pharmaceuticals, S.L.
Albany Gate, Darkes Lane Via Vittor Pisani 20 C/Plom 2-4, 5a planta
Potter Bar EN6 1AG, 20124 Milano, 08038 Barcelona / GB
Opponent's representative
Elend, Almut Susanne, et al, et al
Venner Shipley LLP
Byron House
Cambridge Business Park
Cowley Road
Cambridge CB4 0WZ / GB
 04  12.10.2009  08.05.2012  WITHDRAWN
Ratiopharm GmbH
Graf-Arco-Strasse 3
89079 Ulm / DE
Opponent's representative
Breuer, Markus, et al, et al
Henkel, Breuer & Partner
Patentanwälte
Erika-Mann-Straße 23
80636 München / DE
 05  13.10.2009  02.11.2009  ADMISSIBLE
ALAPIS S.A.
Aftokratoros Nikolaou Str. 1
17671 Athens / GR
Opponent's representative
Roukounas, Dimitrios
13, Agamemnonos Street
155 61 Holargos, Athens / GR
Former [2013/13]
Opponent(s)01  11.07.2009  21.06.2012  WITHDRAWN
Breath Limited
100 Paynesfield Road Tatsfield
Westerham TN16 2BQ / GB
Opponent's representative
Schlich, George William, et al, et al
Schlich LLP
9 St Catherine's Road
Littlehampton
West Sussex BN17 5HS / GB
 02  31.07.2009  10.08.2009  ADMISSIBLE
Lareq Pharma SL
Calle Caléndula 93 Edificio G, Miniparc III, Urbanizaciõn El Soto
Alcobendas Madrid / ES
Opponent's representative
Nohlen, Martin, et al, et al
Uexküll & Stolberg Patentanwälte Beselerstrasse 4
22607 Hamburg / DE
 03  17.08.2009  16.09.2009  WITHDRAWN
Generics (UK) Limited Mylan Italy, Mylan S.p.A Mylan Spain, Mylan Pharmaceuticals, S.L.
Albany Gate, Darkes Lane Via Vittor Pisani 20 C/Plom 2-4, 5a planta
Potter Bar EN6 1AG, 20124 Milano, 08038 Barcelona / GB
Opponent's representative
Elend, Almut Susanne, et al, et al
Venner Shipley LLP
Byron House
Cambridge Business Park
Cowley Road
Cambridge CB4 0WZ / GB
 04  12.10.2009  08.05.2012  WITHDRAWN
Ratiopharm GmbH
Graf-Arco-Strasse 3
89079 Ulm / DE
Opponent's representative
Breuer, Markus, et al, et al
Henkel, Breuer & Partner
Patentanwälte
Erika-Mann-Straße 23
80636 München / DE
 05  13.10.2009  02.11.2009  ADMISSIBLE
ALAPIS S.A.
Aftokratoros Nikolaou Str. 1
17671 Athens / GR
Former [2012/31]
Opponent(s)01  11.07.2009  21.06.2012  WITHDRAWN
Breath Limited
100 Paynesfield Road Tatsfield
Westerham TN16 2BQ / GB
Opponent's representative
Clements, Andrew Russell Niel, et al, et al
Schlich LLP
34 New Road
Littlehampton, West Sussex BN17 5AT / GB
 02  31.07.2009  10.08.2009  ADMISSIBLE
Lareq Pharma SL
Calle Caléndula 93 Edificio G, Miniparc III, Urbanizaciõn El Soto
Alcobendas Madrid / ES
Opponent's representative
Nohlen, Martin, et al, et al
Uexküll & Stolberg Patentanwälte Beselerstrasse 4
22607 Hamburg / DE
 03  17.08.2009  16.09.2009  WITHDRAWN
Generics (UK) Limited Mylan Italy, Mylan S.p.A Mylan Spain, Mylan Pharmaceuticals, S.L.
Albany Gate, Darkes Lane Via Vittor Pisani 20 C/Plom 2-4, 5a planta
Potter Bar EN6 1AG, 20124 Milano, 08038 Barcelona / GB
Opponent's representative
Elend, Almut Susanne, et al, et al
Venner Shipley LLP
Byron House
Cambridge Business Park
Cowley Road
Cambridge CB4 0WZ / GB
 04  12.10.2009  08.05.2012  WITHDRAWN
Ratiopharm GmbH
Graf-Arco-Strasse 3
89079 Ulm / DE
Opponent's representative
Breuer, Markus, et al, et al
Henkel, Breuer & Partner
Patentanwälte
Erika-Mann-Straße 23
80636 München / DE
 05  13.10.2009  02.11.2009  ADMISSIBLE
ALAPIS S.A.
Aftokratoros Nikolaou Str. 1
17671 Athens / GR
Former [2012/24]
Opponent(s)01  11.07.2009  21.07.2009  ADMISSIBLE
Breath Limited
100 Paynesfield Road Tatsfield
Westerham TN16 2BQ / GB
Opponent's representative
Clements, Andrew Russell Niel, et al, et al
Schlich LLP
34 New Road
Littlehampton, West Sussex BN17 5AT / GB
 02  31.07.2009  10.08.2009  ADMISSIBLE
Lareq Pharma SL
Calle Caléndula 93 Edificio G, Miniparc III, Urbanizaciõn El Soto
Alcobendas Madrid / ES
Opponent's representative
Nohlen, Martin, et al, et al
Uexküll & Stolberg Patentanwälte Beselerstrasse 4
22607 Hamburg / DE
 03  17.08.2009  16.09.2009  WITHDRAWN
Generics (UK) Limited Mylan Italy, Mylan S.p.A Mylan Spain, Mylan Pharmaceuticals, S.L.
Albany Gate, Darkes Lane Via Vittor Pisani 20 C/Plom 2-4, 5a planta
Potter Bar EN6 1AG, 20124 Milano, 08038 Barcelona / GB
Opponent's representative
Elend, Almut Susanne, et al, et al
Venner Shipley LLP
Byron House
Cambridge Business Park
Cowley Road
Cambridge CB4 0WZ / GB
 04  12.10.2009  08.05.2012  WITHDRAWN
Ratiopharm GmbH
Graf-Arco-Strasse 3
89079 Ulm / DE
Opponent's representative
Breuer, Markus, et al, et al
Henkel, Breuer & Partner
Patentanwälte
Erika-Mann-Straße 23
80636 München / DE
 05  13.10.2009  02.11.2009  ADMISSIBLE
ALAPIS S.A.
Aftokratoros Nikolaou Str. 1
17671 Athens / GR
Former [2012/19]
Opponent(s)01  11.07.2009  21.07.2009  ADMISSIBLE
Breath Limited
100 Paynesfield Road Tatsfield
Westerham TN16 2BQ / GB
Opponent's representative
Clements, Andrew Russell Niel, et al, et al
Schlich LLP
34 New Road
Littlehampton, West Sussex BN17 5AT / GB
 02  31.07.2009  10.08.2009  ADMISSIBLE
Lareq Pharma SL
Calle Caléndula 93 Edificio G, Miniparc III, Urbanizaciõn El Soto
Alcobendas Madrid / ES
Opponent's representative
Nohlen, Martin, et al, et al
Uexküll & Stolberg Patentanwälte Beselerstrasse 4
22607 Hamburg / DE
 03  17.08.2009  16.09.2009  WITHDRAWN
Generics (UK) Limited Mylan Italy, Mylan S.p.A Mylan Spain, Mylan Pharmaceuticals, S.L.
Albany Gate, Darkes Lane Via Vittor Pisani 20 C/Plom 2-4, 5a planta
Potter Bar EN6 1AG, 20124 Milano, 08038 Barcelona / GB
Opponent's representative
Elend, Almut Susanne, et al, et al
Venner Shipley LLP
Byron House
Cambridge Business Park
Cowley Road
Cambridge CB4 0WZ / GB
 04  12.10.2009  22.10.2009  ADMISSIBLE
Ratiopharm GmbH
Graf-Arco-Strasse 3
89079 Ulm / DE
Opponent's representative
Breuer, Markus, et al, et al
Henkel, Breuer & Partner
Patentanwälte
Erika-Mann-Straße 23
80636 München / DE
 05  13.10.2009  02.11.2009  ADMISSIBLE
ALAPIS S.A.
Aftokratoros Nikolaou Str. 1
17671 Athens / GR
Former [2012/17]
Opponent(s)01  11.07.2009  21.07.2009  ADMISSIBLE
Breath Limited
100 Paynesfield Road Tatsfield
Westerham TN16 2BQ / GB
Opponent's representative
Clements, Andrew Russell Niel, et al, et al
Schlich LLP
34 New Road
Littlehampton, West Sussex BN17 5AT / GB
 02  31.07.2009  10.08.2009  ADMISSIBLE
Lareq Pharma SL
Calle Caléndula 93 Edificio G, Miniparc III, Urbanizaciõn El Soto
Alcobendas Madrid / ES
Opponent's representative
Nohlen, Martin, et al, et al
Uexküll & Stolberg Patentanwälte Beselerstrasse 4
22607 Hamburg / DE
 03  17.08.2009  16.09.2009  WITHDRAWN
Generics (UK) Limited Mylan Italy, Mylan S.p.A Mylan Spain, Mylan Pharmaceuticals, S.L.
Albany Gate, Darkes Lane Via Vittor Pisani 20 C/Plom 2-4, 5a planta
Potter Bar EN6 1AG, 20124 Milano, 08038 Barcelona / GB
Opponent's representative
Elend, Almut Susanne, et al, et al
Venner Shipley LLP
Byron House
Cambridge Business Park
Cowley Road
Cambridge CB4 0WZ / GB
 04  12.10.2009  22.10.2009  ADMISSIBLE
Ratiopharm GmbH
Graf-Arco-Strasse 3
89079 Ulm / DE
Opponent's representative
Breuer, Markus, et al, et al
Henkel, Breuer & Partner
Patentanwälte
Erika-Mann-Straße 23
80636 München / DE
 05  13.10.2009  02.11.2009  ADMISSIBLE
ALAPIS S.A.
Aftokratoros Nikolaou Str. 1
17671 Athens / GR
Opponent's representative
Roukounas, Dimitrios
13, Agamemnonos Street
155 61 Holargos, Athens / GR
Former [2009/48]
Opponent(s)01  11.07.2009  21.07.2009  ADMISSIBLE
Breath Limited
100 Paynesfield Road Tatsfield
Westerham TN16 2BQ / GB
Opponent's representative
Clements, Andrew Russell Niel, et al, et al
Schlich & Co 34 New Road
Littlehampton, West Sussex BN17 5AT / GB
 02  31.07.2009  10.08.2009  ADMISSIBLE
Lareq Pharma SL
Calle Caléndula 93 Edificio G, Miniparc III, Urbanizaciõn El Soto
Alcobendas Madrid / ES
Opponent's representative
Nohlen, Martin, et al, et al
Uexküll & Stolberg Patentanwälte Beselerstrasse 4
22607 Hamburg / DE
 03  17.08.2009  16.09.2009  ADMISSIBLE
Generics (UK) Limited Mylan Italy, Mylan S.p.A Mylan Spain, Mylan Pharmaceuticals, S.L.
Albany Gate, Darkes Lane Via Vittor Pisani 20 C/Plom 2-4, 5a planta
Potter Bar EN6 1AG, 20124 Milano, 08038 Barcelona / GB
Opponent's representative
Elend, Almut Susanne, et al, et al
Venner Shipley LLP Byron House Cambridge Business Park Cowley Road
GB-Cambridge CB4 0WZ / GB
 04  12.10.2009  22.10.2009  ADMISSIBLE
Ratiopharm GmbH
Graf-Arco-Strasse 3
89079 Ulm / DE
Opponent's representative
Breuer, Markus, et al, et al
Breuer & Müller Partnerschaft Patentanwälte Heimeranstrasse 35
80339 München / DE
 05  13.10.2009   
ALAPIS S.A.
Aftokratoros Nikolaou Str. 1
17671 Athens / GR
Opponent's representative
Roukounas, Dimitrios
13, Agamemnonos Street
155 61 Holargos, Athens / GR
Former [2009/39]
Opponent(s)01  11.07.2009  21.07.2009  ADMISSIBLE
Breath Limited
100 Paynesfield Road Tatsfield
Westerham TN16 2BQ / GB
Opponent's representative
Clements, Andrew Russell Niel, et al, et al
Schlich & Co 34 New Road
Littlehampton, West Sussex BN17 5AT / GB
 02  31.07.2009  10.08.2009  ADMISSIBLE
Lareq Pharma SL
Calle Caléndula 93 Edificio G, Miniparc III, Urbanizaciõn El Soto
Alcobendas Madrid / ES
Opponent's representative
Nohlen, Martin, et al, et al
Uexküll & Stolberg Patentanwälte Beselerstrasse 4
22607 Hamburg / DE
 03  17.08.2009   
Generics (UK) Limited Mylan Italy, Mylan S.p.A Mylan Spain, Mylan Pharmaceuticals, S.L.
Albany Gate, Darkes Lane Via Vittor Pisani 20 C/Plom 2-4, 5a planta
Potter Bar EN6 1AG, 20124 Milano, 08038 Barcelona / GB
Opponent's representative
Elend, Almut Susanne, et al, et al
Venner Shipley LLP Byron House Cambridge Business Park Cowley Road
GB-Cambridge CB4 0WZ / GB
Former [2009/37]
Opponent(s)01  11.07.2009  21.07.2009  ADMISSIBLE
Breath Limited
100 Paynesfield Road Tatsfield
Westerham TN16 2BQ / GB
Opponent's representative
Clements, Andrew Russell Niel, et al, et al
Schlich & Co 34 New Road
Littlehampton, West Sussex BN17 5AT / GB
 02  31.07.2009    ADMISSIBLE
Lareq Pharma SL
Calle Caléndula 93 Edificio G, Miniparc III, Urbanizaciõn El Soto
Alcobendas Madrid / ES
Opponent's representative
Nohlen, Martin, et al, et al
Uexküll & Stolberg Patentanwälte Beselerstrasse 4
22607 Hamburg / DE
Former [2009/34]
Opponent(s)01  11.07.2009   
Breath Limited
100 Paynesfield Road Tatsfield
Westerham TN16 2BQ / GB
Opponent's representative
Clements, Andrew Russell Niel, et al, et al
Schlich & Co 34 New Road
Littlehampton, West Sussex BN17 5AT / GB
19.11.2009Invitation to proprietor to file observations on the notice of opposition
25.03.2010Reply of patent proprietor to notice(s) of opposition
05.10.2010Date of oral proceedings
15.11.2010Despatch of minutes of oral proceedings
15.11.2010Despatch of communication that the patent will be revoked
04.02.2013Despatch of a communication from the opposition division (Time limit: M04)
11.04.2013Reply to a communication from the opposition division
04.06.2013Despatch of interlocutory decision in opposition
14.06.2014Legal effect of interlocutory decision in opposition
22.09.2014Despatch of communication that the patent will be maintained as amended
09.12.2014Fee for printing new specification paid
Appeal following opposition15.11.2010Appeal received No.  T2402/10
23.03.2011Statement of grounds filed
10.05.2012Result of appeal procedure: maintenance in amended form
10.05.2012Date of oral proceedings
22.05.2012Minutes of the oral proceedings despatched
Fees paidRenewal fee
11.06.2002Renewal fee patent year 03
11.06.2002Renewal fee patent year 04
11.06.2002Renewal fee patent year 05
11.06.2002Renewal fee patent year 06
11.06.2002Renewal fee patent year 07
11.06.2002Renewal fee patent year 08
11.06.2002Renewal fee patent year 09
11.06.2002Renewal fee patent year 10
11.06.2002Renewal fee patent year 11
11.06.2002Renewal fee patent year 12
11.06.2002Renewal fee patent year 13
25.07.2002Renewal fee patent year 14
04.09.2003Renewal fee patent year 15
06.09.2004Renewal fee patent year 16
05.09.2005Renewal fee patent year 17
08.09.2006Renewal fee patent year 18
05.09.2007Renewal fee patent year 19
05.09.2008Renewal fee patent year 20
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAT14.01.2009
BE14.01.2009
NL14.01.2009
SE14.04.2009
GR15.04.2009
GB05.09.2009
ES07.09.2009
[2015/49]
Former [2010/47]AT14.01.2009
BE14.01.2009
NL14.01.2009
SE14.04.2009
GR15.04.2009
GB05.09.2009
ES18.03.2010
Former [2010/23]AT14.01.2009
BE14.01.2009
NL14.01.2009
SE14.04.2009
GB05.09.2009
ES18.03.2010
Former [2010/19]AT14.01.2009
BE14.01.2009
NL14.01.2009
SE14.04.2009
ES18.03.2010
Former [2009/43]AT14.01.2009
BE14.01.2009
NL14.01.2009
SE14.04.2009
Former [2009/40]AT14.01.2009
NL14.01.2009
SE14.04.2009
Former [2009/38]NL14.01.2009
SE14.04.2009
Former [2009/26]NL14.01.2009
Documents cited:Search[X]US3962312  (HAYASHI MASAKI, et al) [X] 1,2 * claim - *;
 [X]EP0093380  (UNIV COLUMBIA [US]) [X] 1-6 * claims 1,5-16; table 3 *;
 [A]EP0170258  (SYNTEX INC [US]) [A] 1-6* claim - *
OppositionDE2234709
 GB1362956
 GB1364125
 US3962312
 CA1208560
    - E. GRANSTRÖM, Prostaglandins, (197501), vol. 9, pages 19 - 45
    - The Association for Research in Ophtalmology - Annual Spring Meeting, (198805), vol. 29, page 325
    - ARVO Abstracts 1987
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.